OverviewChartNewsTraderScreen

Global Profit Technologies, Inc./  US37949N1054  /

Nasdaq Other OTC
18/09/2023  15:30:01 Chg. - Volume Bid- Ask- High Low
0.0003USD - 6,928
Turnover: 2.0784		 -Bid Size: - -Ask Size: - 0.0003 0.0003
GlobeNewswire 14/11/2023 Immatics Announces Third Quarter 2023 Financial Results and Business Update
GlobeNewswire 11/09/2023 Moderna and Immatics Announce Strategic Multi-Platform Collaboration to Develop Innovative Oncology...
GlobeNewswire 16/03/2022 Biogen Announces Peer-Reviewed Publication of ADUHELM® Phase 3 EMERGE and ENGAGE Data in The Journal...
GlobeNewswire 21/09/2021 OSE Immunotherapeutics Announces H1 2021 Results and Provides a Corporate Update
GlobeNewswire 26/03/2021 OSE Immunotherapeutics Reports 2020 Financial Results and Provides Business Update
GlobeNewswire 16/01/2021 American Lithium Comments on Recent Promotional Activity
GlobeNewswire 17/09/2020 OSE Immunotherapeutics Reports First Half 2020 Results and Corporate Update
GlobeNewswire 30/04/2020 AB Science reports today its annual financials as of 31 December 2019
GlobeNewswire 26/03/2020 OSE Immunotherapeutics Reports 2019 Financial Results and Provides Business Update Expectations for ...
GlobeNewswire 05/09/2019 OSE Immunotherapeutics Reports First Half 2019 Results and Provides a Corporate Update
GlobeNewswire 30/07/2019 Global Profit Technologies, Inc. Announces Issuance of its “GCU” Trademark by USPTO
GlobeNewswire 08/07/2019 Global Profit Technologies, Inc. Announces Release of Global Currency Unit (“GCU”)
GlobeNewswire 03/07/2019 Global Profit Technologies, Inc. Announces Release of Global Currency Unit (“GCU”)
GlobeNewswire 18/06/2019 Wildflower Featured in CannabisNewsWire Publication Highlighting Legal Cannabis as a Global Profit P...
GlobeNewswire 30/04/2019 AB Science reports today its annual financials as of 31 December 2018 and provides an update on its ...
GlobeNewswire 28/03/2019 OSE Immunotherapeutics Reports 2018 Financial Results and Business Update
GlobeNewswire 06/09/2018 OSE Immunotherapeutics Reports First-Half 2018 Results and Provides a Corporate Update
GlobeNewswire 06/08/2018 Cara Therapeutics Appoints Christopher A. Posner to Board of Directors
GlobeNewswire 30/04/2018 AB Science reports today its annual financials as of 31 December 2017 and provides an update on its ...
GlobeNewswire 30/04/2018 AB Science reports today its annual financials as of 31 December 2017 and provides an update on its ...
GlobeNewswire 28/03/2018 OSE Immunotherapeutics: 2017 Annual Results and Clinical Advances of its Proprietary and Partnered P...
GlobeNewswire 22/03/2018 BOLLORE : 2017 Results
GlobeNewswire 01/05/2017 AB Science reports today its annual financials as of 31 December 2016 and provides an update on its ...
GlobeNewswire 01/05/2017 AB Science reports today its annual financials as of 31 December 2016 and provides an update on its ...
GlobeNewswire 28/03/2017 2016 Results: Significant Milestones, First Profit, More Growth to Come